Bruno Sangro - Publications, H-index & Citations

Bruno Sangro

Clinica Universidad de Navarra and Ciberehd

95H指数

815论文数

4.8W被引数

收录论文 284

发表时间

Journal of Hepatology

IF33

2026-07-25

PREAI

Stephen L. Chan; Bruno Sangro; Lorenza Rimassa

Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma 组蛋白甲基转移酶G9a抑制增强了免疫检查点抑制剂在实验性肝细胞癌中的疗效

Cell Reports Medicine

IF10.6

2026-03-31

OAAI

Elena Adan-Villaescusa; Borja Castello-Uribe; Iker Uriarte; Eva Santamaria; Roberto Barbero; Miriam Belzunce; Amaya López-Pascual; Maria Ujue Latasa; Jasmin Elurbide; Emiliana Valbuena-Goiricelaya; Agavni Mesropian; Guillem Cano-Segarra; Ana Hernández de Sande; Lorenzo Nevi; Simone Carotti; Umberto Vespasiani-Gentilucci; Felipe Prosper; Antonio Pineda-Lucena; Bruno Sangro; Josepmaria Argemi

Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy 接受联合放射免疫治疗的肝细胞癌患者来源新抗原的免疫原性

OncoImmunology

IF6.3

2026-03-18

OAAI

Belén Aparicio; Leyre Silva; Marta Ruiz; Diana Llópiz; David Repáraz; Patrick Theunissen; Ibon Tamayo; Josune Egea; Ana Igea; Cristian Smerdou; Maria Peñas; Cristina Perpiñá; Ana Matilla; María Varela; Maria Reig; Manuel de la Torre-Alaez; Josepmaria Argemí; Bruno Sangro; Sandra Hervás-Stubbs; Pablo Sarobe

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma 三叶因子-3是缺氧诱导的肝母细胞瘤促肿瘤因子

Liver International

IF5.2

2026-03-13

OAAI

Luz A. Martínez-Pérez; M. Ujue Latasa; Iker Uriarte; Amaya López-Pascual; Jasmin Elurbide; Pavel Strnad; Sona Frankova; Eva Sticova; Ondrej Fabian; Maria Arechederra; Eva Santamaria; Josepmaria Argemi; Bruno Sangro; Beatrice Foglia; Maurizio Parola; Melva Gutiérrez-Angulo; Stefano Cairo; Ramón Bataller; Pau Sancho-Bru; Maria L. Martinez-Chantar; Jose J. G. Marin; Andrea Castaneda; Carolina Armengol; Carmen Berasain; Maite G. Fernandez-Barrena; Matias A. Ávila

A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells 肝脏基因签名将慢性病毒性肝炎的肝癌风险与肝内IgA浆细胞联系起来

JHEP Reports

IF7.5

2025-12-19

OAAI

Nicolaas Van Renne; Fleur Ballet; Stijn Van Hees; Bart Cuypers; Arno Furquim d’Almeida; Axelle Vanderlinden; Pieter Meysman; Jordan J. Feld; Paloma Sangro del Alcázar; Stefan Bourgeois; Dirk Sprengers; Geert Robaeys; Luisa Vonghia; Peter Michielsen; Sven Francque; Bruno Sangro; Owen Cain; Ahmed M. Elsharkawy; Rob De Man; Andre Boonstra

Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis IIIb期SIERRA研究早期安全性结果：度伐利尤单抗和特瑞普利单抗作为不可切除肝细胞癌且预后不良患者的一线治疗方案。

Liver Cancer

IF9.1

2025-12-01

OAAI

Chan, Stephen Lam; Kudo, Masatoshi; Sangro, Bruno; Kelley, Robin Kate; Kim, Jee Hyun; Pham, Binh; Hong, Jung Yong; Waldschmidt, Dirk-Thomas; Marino, Donatella; Lee, Jie Xin Joycelyn; Gerolami, Rene; Burgoyne, Adam M.; Li, Qiao; Nakamura, Hitomi; Sun, Peng; Baur, Boris; Rimassa, Lorenza

In vitro and in silico assessment of a multi side-hole catheter for transcatheter endovascular treatments on arterial bifurcations 体外和计算机模拟评估一种多侧孔导管在经导管腔内治疗动脉分叉处的应用

Results in Engineering

IF7.9

2025-11-28

OAAI

Julio Ortega; Raúl Antón; Juan.C. Ramos; Alejandro Rivas; Gorka.S. Larraona; Bruno Sangro; José I. Bilbao; Jorge Aramburu

Response evaluation to systemic therapy in HCC: Current challenges and future perspectives 对HCC系统性治疗的反应评估：当前挑战与未来展望

HEPATOLOGY

IF15.8

2025-11-01

PREAI

Matute-Gonzalez, Mario; Ronot, Maxime; Chernyak, Victoria; Sangro, Bruno; Rimola, Jordi

Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR 更正：EORTC和ESGAR关于局部和局部区域治疗中肝细胞癌分期、治疗计划制定和监测的影像学应用：共识建议

European Radiology

IF4.7

2025-10-31

OAAI

Osman Öcal; Christoph Johannes Zech; Maria Antonietta Bali; David Pasquier; Felix Mottaghy; Ingo Einspieler; Nikolaos Kartalis; Irene Bargellini; Roberto Iezzi; Timm Denecke; Wolfgang Gerhard Kunz; Bernhard Gebauer; Henning Wege; Roberto Cannella; Daniela Elena Oprea-Lager; Arndt Vogel; Bruno Sangro; Max Seidensticker

BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update 用于预后预测和治疗建议的BCLC策略: 2025更新

Journal of Hepatology

IF33

2025-10-27

PREAI

Maria Reig; Marco Sanduzzi-Zamparelli; Alejandro Forner; Jordi Rimola; Joana Ferrer-Fàbrega; Marta Burrel; Ángeles Garcia-Criado; Alba Díaz; Neus Llarch; Gemma Iserte; Meritxell Mollà; Robin K. Kelley; Peter R. Galle; Vincenzo Mazzaferro; Riad Salem; Bruno Sangro; Amit Singal; Arndt Vogel; Ted K. Yanagihara; Carmen Ayuso; Ferran Torres; Jordi Bruix

Unexplained early deaths in EMERALD-1: is liver failure the reason? – Authors' reply EMERALD-1研究中无法解释的早期死亡：是肝脏衰竭的原因吗？——作者回复

The Lancet

IF97.3

2025-10-02

PREAI

Bruno Sangro; Stephen L Chan

Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next?免疫检查点抑制剂在胆道癌中的应用：谁将受益，未来何在？

Cancers 2025, Vol. 17, Page 2811

IF4.4

2025-08-29

OAAI

Lucía Ceniceros; Manuel de La Torre; Ana Landa Magdalena; Paloma Sangro; Josepmaria Argemí; Delia D’Avola; Bruno Sangro; Mariano Ponz-Sarvisé

Tremelimumab for the treatment of hepatocellular carcinoma Tremelimumab for the treatment of hepatocellular carcinoma 替拉木单抗用于治疗肝细胞癌

Expert Opinion on Biological Therapy

IF4

2025-08-21

PREAI

Miguel Sogbe; Paloma Sangro; Manuel de la Torre-Aláez; Bruno Sangro

Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association 肝癌患者系统性治疗可及性差异：国际肝病肿瘤协会的分析

lancet regional health europe

IF0

2025-07-31

PREAI

Manon Allaire; Leonardo G. Da Fonseca; Marco Sanduzzi-Zamparelli; Won-Mook Choi; Cecilia Monge; Ken Liu; Michael Leibfried; Sarah Manes; Zorana Maravic; Milan Mishkovikj; Jordi Bruix; Helen L. Reeves; Riad Salem; Bruno Sangro

Expression landscape of epigenetic genes in human hepatocellular carcinoma 人类肝细胞癌中表观遗传基因的表达景观

Journal of Physiology and Biochemistry

IF4.3

2025-06-12

OAAI

Borja Castelló-Uribe; Amaya López-Pascual; Jasmin Elurbide; Elena Adán-Villaescusa; Emiliana Valbuena-Goiricelaya; Luz A. Martinez-Perez; Iker Uriarte; M. Ujúe Latasa; Bruno Sangro; María Arechederra; Carmen Berasain; Matías A. Avila; Maite G. Fernández-Barrena

Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR 在局部和局部区域治疗中，肝细胞癌分期、治疗计划和监测的影像学应用：EORTC和ESGAR的共识建议

EUROPEAN RADIOLOGY

IF4.7

2025-05-23

OAAI

Oecal, Osman; Zech, Christoph Johannes; Bali, Maria Antonietta; Pasquier, David; Mottaghy, Felix; Einspieler, Ingo; Kartalis, Nikolaos; Bargellini, Irene; Iezzi, Roberto; Denecke, Timm; Kunz, Wolfgang Gerhard; Gebauer, Bernhard; Wege, Henning; Cannella, Roberto; Oprea-Lager, Daniela Elena; Vogel, Arndt; Sangro, Bruno; Seidensticker, Max

Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC HIMALAYA研究五-year总体生存率更新：曲美木单抗联合度伐利尤单抗治疗不可切除性HCC

Journal of Hepatology

IF33

2025-04-11

OAAI

Lorenza Rimassa; Stephen L. Chan; Bruno Sangro; George Lau; Masatoshi Kudo; Maria Reig; Valeriy Breder; Min-Hee Ryu; Yuriy Ostapenko; Wattana Sukeepaisarnjaroen; Maria Varela; David Tougeron; Oxana V. Crysler; Mohamed Bouattour; Tu Van Dao; Vincent C. Tam; Adilson Faccio; Junji Furuse; Long-Bin Jeng; Yoon Koo Kang; Robin K. Kelley; Michael J. Paskow; Di Ran; Ioannis Xynos; John F. Kurland; Alejandra Negro; Ghassan K. Abou-Alfa

Reply to: “Ruptured HCC: An entity in exile from the EASL Clinical Practice Guidelines!”回复：“破裂的HCC：一个被排除在EASL临床实践指南之外的实体！”

Journal of Hepatology

IF33

2025-04-11

PREAI

Bruno Sangro; Vincenzo Mazzaferro

MORPHEUS-Liver provides a way forward in expanding the immunotherapy options for hepatocellular carcinoma MORPHEUS-肝脏为扩大肝细胞癌的免疫治疗选择提供了一条前进的道路

NATURE REVIEWS CLINICAL ONCOLOGY

IF82.2

2025-03-10

PREAI

Sangro, B; Argemi, J

Transarterial chemoembolisation with irinotecan (irinotecan-TACE) as salvage or post-inductive therapy for colorectal cancer liver metastases: effectiveness results from the CIREL study

ESMO OPEN

IF8.3

2025-03-01

PREAI

Arnold, D.; Pereira, P. L.; Iezzi, R.; Gjoreski, A.; Spiliopoulos, S.; Helmberger, T.; Gomez, F. M.; de Baere, T.; Pellerin, O.; Maleux, G.; Prenen, H.; Sangro, B.; Zeka, B.; Kaufmann, N. C.; Taieb, J.

研究方向